Home > News > After a pause, buckyballs make it to the big time
October 17th, 2003
After a pause, buckyballs make it to the big time
Buckyballs, the soccer ball-shaped molecules that helped kick-start interest in nanoscale science and technology in the 1990s, finally made the big time. The biotech startup C Sixty announced Thursday that it is partnering with the pharmaceutical company Merck & Co. to develop drugs based on buckyballs, formally known as buckminsterfullerenes. If they are successful, fullerenes could find a use that is both medically beneficial and lucrative, and open the door for high-volume production of fullerenes.
Nanoscale assembly line August 29th, 2014
Copper shines as flexible conductor August 29th, 2014
Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices August 28th, 2014
PetLife Comments on CNN Story on Scorpion Venom Health Benefits August 27th, 2014